Assessment of Long-Term Pulmonary Function and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD)

被引:0
|
作者
Gabhale, Sanjay D. [1 ]
Bagrecha, Mahavir Satishchand [2 ]
Dash, Mitali [3 ]
Sheikh, Zeeshan [4 ]
Bhuvaneshwari, S. [5 ]
Imran, Rangraze [6 ]
Satheesh, Tharini [7 ]
机构
[1] Dr DY Patil Vidyapeeth, Dr DY Patil Med Coll Hosp & Res Ctr, Dept Resp Med, Pune, Maharashtra, India
[2] Dr DY Patil Med Coll Hosp & Res Ctr, Dept Pulm Med, Pune, Maharashtra, India
[3] SCB Med Coll, Dept Pathol, Cuttack, Odisha, India
[4] RD Gardi Med Coll, Ujjain, Madhya Pradesh, India
[5] KIIT Deemed Univ, Kalinga Inst Dent Sci, Bhubaneswar, Odisha, India
[6] RAK Med & Hlth Sci Univ, Dept Internal Med, Ras Al Khaymah, U Arab Emirates
[7] Dube Surg & Dent Hosp, AOMSI, Jabalpur, Madhya Pradesh, India
关键词
Chronic obstructive pulmonary disease; COPD; longitudinal research; pulmonary function; QoL; PREVENTION;
D O I
10.4103/jpbs.jpbs_252_24
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory condition portrayed by persistent airflow limitation and correlated symptoms. Despite advances in treatment, COPD remains a significant global health burden, necessitating ongoing research to understand its long-standing impact on pulmonary function and quality of life (QoL). Methods: This longitudinal research enrolled 200 COPD and followed them over a 5-year period. Baseline assessments included spirometry to measure forced expiratory volume in one second (FEV1) and forced vital capacity (FVC), along with standardized questionnaires assessing QoL. Follow-up assessments were conducted annually, and statistical analysis was performed to examine changes in pulmonary function and QoL over time. Results: Significant declines in FEV1 and FVC were observed at each follow-up time point compared to the baseline, indicating progressive deterioration in lung function. QoL scores, as assessed by the St. George's Respiratory Questionnaire and the COPD Assessment Test, also worsened progressively over the research period. Conclusion: Current conclusions underscore the progressive nature of COPD, highlighting the importance of proactive management strategies aimed at preserving lung function and improving QoL. Early intervention and ongoing monitoring are essential in optimizing outcomes for COPD subjects and reducing the disease burden on individuals and healthcare systems.
引用
收藏
页码:S2737 / S2739
页数:3
相关论文
共 50 条
  • [21] Lung function and long-term safety of tiotropium/olodaterol in East Asian patients with chronic obstructive pulmonary disease
    Bai, Chunxue
    Ichinose, Masakazu
    Lee, Sang Haak
    Lee, Kwan Ho
    Joens, Olaf
    Bothner, Ulrich
    Zhao, Yihua
    Buhl, Roland
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 3329 - 3339
  • [22] Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease
    Naderi, Nafiseh
    Assayag, Deborah
    Mostafavi-Pour-Manshadi, Seyed-Mohammad-Yousof
    Kaddaha, Zeina
    Joubert, Alexandre
    Ouellet, Isabelle
    Drouin, Isabelle
    Li, Pei Zhi
    Bourbeau, Jean
    RESPIRATORY MEDICINE, 2018, 138 : 129 - 136
  • [23] Use of long-term macrolide therapy in chronic obstructive pulmonary disease
    Ramos, Frederick L.
    Criner, Gerard J.
    CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (02) : 153 - 158
  • [24] Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a long-term benefit?
    Highland, KB
    CURRENT OPINION IN PULMONARY MEDICINE, 2004, 10 (02) : 113 - 119
  • [25] Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia?
    Okubadejo, AA
    Paul, EA
    Jones, PW
    Wedzicha, JA
    EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (11) : 2335 - 2339
  • [26] Detection of quality of life with COPD assessment test in chronic obstructive pulmonary disease and effect of dyspnea on disease-specific quality of life in these patients
    Okutan, Oguzhan
    Tas, Dilaver
    Demirer, Ersin
    Kartaloglu, Zafer
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [27] Improved quality of life associated with long-term use of guaifenesin in a patient with chronic obstructive pulmonary disease (COPD) & stable chronic bronchitis: A case report
    Singer, Ethan
    Miller, Judi E.
    RESPIRATORY MEDICINE CASE REPORTS, 2019, 26 : 9 - 10
  • [28] Chronic bronchial infection and incident cardiovascular events in chronic obstructive pulmonary disease patients: A long-term observational study
    Martinez-Garcia, Miguel Angel
    Faner, Rosa
    Oscullo, Grace
    la Rosa-Carrillo, David
    Soler-Cataluna, Juan Jose
    Ballester, Marta
    Muriel, Alfonso
    Agusti, Alvar
    RESPIROLOGY, 2021, 26 (08) : 776 - 785
  • [29] Inhaled Corticosteroids in the Long-Term Management of Patients with Chronic Obstructive Pulmonary Disease
    Don D. Sin
    S. F. Paul Man
    Drugs & Aging, 2003, 20 : 867 - 880
  • [30] Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy
    Blasi, Francesco
    Bonardi, Daniela
    Aliberti, Stefano
    Tarsia, Paolo
    Confalonieri, Marco
    Amir, Omar
    Carone, Mauro
    Di Marco, Fabiano
    Centanni, Stefano
    Guffanti, Enrico
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2010, 23 (03) : 200 - 207